REATA PHARMACEUTICALS INC Net Income
REATA PHARMACEUTICALS INC reported Net Income of $193.00 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-08-08
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2023-06-30 was $193.00M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$116.12M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2022-12-31 was -$85.50M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$79.00M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2022 was -$311.90M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2021 was -$297.39M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2020 was -$247.75M.
- REATA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2019 was -$290.17M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-06-30 | $193.00M 10-Q · filed 2023-08-08 | $76.88M 10-Q · filed 2023-08-08 | -$8.62M derived: sum of 3 quarters · filed 2023-08-08 | -$87.62M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | -$116.12M 10-Q · filed 2023-05-10 | -$201.62M derived: sum of 2 quarters · filed 2023-05-10 | -$280.62M derived: sum of 3 quarters · filed 2023-05-10 | -$354.18M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | -$85.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$164.50M derived: sum of 2 quarters · filed 2023-02-24 | -$238.06M derived: sum of 3 quarters · filed 2023-08-08 | -$311.90M 10-K · filed 2023-02-24 |
| 2022-09-30 | -$79.00M 10-Q · filed 2022-11-08 | -$152.56M derived: sum of 2 quarters · filed 2023-08-08 | -$226.40M 10-Q · filed 2022-11-08 | -$311.78M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | -$73.56M 10-Q · filed 2023-08-08 | -$147.40M 10-Q · filed 2023-08-08 | -$232.78M derived: sum of 3 quarters · filed 2023-08-08 | -$304.63M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$73.84M 10-Q · filed 2023-05-10 | -$159.23M derived: sum of 2 quarters · filed 2023-05-10 | -$231.07M derived: sum of 3 quarters · filed 2023-05-10 | -$303.77M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$85.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$157.23M derived: sum of 2 quarters · filed 2023-02-24 | -$229.93M derived: sum of 3 quarters · filed 2023-02-24 | -$297.39M 10-K · filed 2023-02-24 |
| 2021-09-30 | -$71.85M 10-Q · filed 2022-11-08 | -$144.55M derived: sum of 2 quarters · filed 2022-11-08 | -$212.00M 10-Q · filed 2022-11-08 | -$277.78M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$72.70M 10-Q · filed 2022-08-08 | -$140.16M 10-Q · filed 2022-08-08 | -$205.93M derived: sum of 3 quarters · filed 2022-08-08 | -$271.39M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$67.45M 10-Q · filed 2022-05-10 | -$133.23M derived: sum of 2 quarters · filed 2022-05-10 | -$198.69M derived: sum of 3 quarters · filed 2022-05-10 | -$266.27M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$65.78M 10-K · filed 2021-03-01 | -$131.23M derived: sum of 2 quarters · filed 2021-11-08 | -$198.81M derived: sum of 3 quarters · filed 2021-11-08 | -$247.75M 10-K · filed 2023-02-24 |
| 2020-09-30 | -$65.46M 10-Q · filed 2021-11-08 | -$133.04M derived: sum of 2 quarters · filed 2021-11-08 | -$181.98M 10-Q · filed 2021-11-08 | -$368.92M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$67.58M 10-Q · filed 2021-08-09 | -$116.52M 10-Q · filed 2021-08-09 | -$303.46M derived: sum of 3 quarters · filed 2021-08-09 | -$343.16M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$48.94M 10-Q · filed 2021-05-06 | -$235.88M derived: sum of 2 quarters · filed 2021-05-06 | -$275.57M derived: sum of 3 quarters · filed 2021-05-06 | -$309.95M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$186.94M 10-K · filed 2021-03-01 | -$226.64M derived: sum of 2 quarters · filed 2021-03-01 | -$261.02M derived: sum of 3 quarters · filed 2021-03-01 | -$290.17M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$39.69M 10-K · filed 2021-03-01 | -$74.07M derived: sum of 2 quarters · filed 2021-03-01 | -$103.23M 10-Q · filed 2020-11-09 | -$128.81M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$34.38M 10-K · filed 2021-03-01 | -$63.53M 10-Q · filed 2020-08-10 | -$89.12M derived: sum of 3 quarters · filed 2021-03-01 | -$119.95M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$29.15M 10-K · filed 2021-03-01 | -$54.74M derived: sum of 2 quarters · filed 2021-03-01 | -$85.57M derived: sum of 3 quarters · filed 2021-03-01 | -$113.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$25.58M 10-K · filed 2020-02-19 | -$56.42M derived: sum of 2 quarters · filed 2020-02-19 | -$84.63M derived: sum of 3 quarters · filed 2020-02-19 | -$80.55M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$30.84M 10-K · filed 2020-02-19 | -$59.05M derived: sum of 2 quarters · filed 2020-02-19 | -$54.96M 10-Q · filed 2019-11-12 | -$71.64M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | -$28.21M 10-K · filed 2020-02-19 | -$24.13M 10-Q · filed 2019-08-08 | -$40.80M derived: sum of 3 quarters · filed 2020-02-19 | -$53.11M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $4.08M 10-K · filed 2020-02-19 | -$12.59M derived: sum of 2 quarters · filed 2020-02-19 | -$24.90M derived: sum of 3 quarters · filed 2020-02-19 | -$36.49M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | -$16.67M 10-K · filed 2019-02-28 | -$28.98M derived: sum of 2 quarters · filed 2019-02-28 | -$40.57M derived: sum of 3 quarters · filed 2019-02-28 | -$47.67M 10-K · filed 2020-02-19 |
| 2017-09-30 | -$12.31M 10-K · filed 2019-02-28 | -$23.90M derived: sum of 2 quarters · filed 2019-02-28 | -$30.99M 10-Q · filed 2018-11-07 | -$35.13M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$11.59M 10-K · filed 2019-02-28 | -$18.69M 10-Q · filed 2018-08-08 | -$22.82M derived: sum of 3 quarters · filed 2019-02-28 | -$23.72M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$7.10M 10-K · filed 2019-02-28 | -$11.23M derived: sum of 2 quarters · filed 2019-02-28 | -$12.13M derived: sum of 3 quarters · filed 2019-02-28 | -$13.07M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$4.14M 10-K · filed 2018-03-02 | -$5.03M derived: sum of 2 quarters · filed 2018-03-02 | -$5.97M derived: sum of 3 quarters · filed 2018-03-02 | -$6.23M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$897.00K 10-K · filed 2018-03-02 | -$1.83M derived: sum of 2 quarters · filed 2018-03-02 | -$2.09M 10-Q · filed 2017-11-13 | -$3.84M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-06-30 | -$936.00K 10-K · filed 2018-03-02 | -$1.19M 10-Q · filed 2017-08-14 | -$2.94M derived: sum of 3 quarters · filed 2018-03-02 | -$2.31M derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-03-31 | -$258.00K 10-K · filed 2018-03-02 | -$2.00M derived: sum of 2 quarters · filed 2018-03-02 | -$1.37M derived: sum of 3 quarters · filed 2018-03-02 | -$3.07M derived: sum of 4 quarters · filed 2018-03-02 |
| 2015-12-31 | -$1.75M 10-K · filed 2017-03-03 | -$1.11M derived: sum of 2 quarters · filed 2017-03-03 | -$2.81M derived: sum of 3 quarters · filed 2017-03-03 | -$1.45M 10-K · filed 2018-03-02 |
| 2015-09-30 | $633.00K 10-K · filed 2017-03-03 | -$1.06M derived: sum of 2 quarters · filed 2017-03-03 | $296.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$1.70M 10-K · filed 2017-03-03 | -$337.00K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $1.36M 10-K · filed 2017-03-03 | |||
| 2014-12-31 | $689.00K 10-K · filed 2017-03-03 |